We report the first case of an HCV-positive recipient who was transplanted with an HCV-positive graft with portal-portal bridging fibrosis. Curbing HCV infection immediately after liver transplant with direct-acting antivirals, resulted in an excellent 9-month outcome. This article is protected by copyright. All rights reserved.
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication
Tandoi, Francesco;
2017-01-01
Abstract
We report the first case of an HCV-positive recipient who was transplanted with an HCV-positive graft with portal-portal bridging fibrosis. Curbing HCV infection immediately after liver transplant with direct-acting antivirals, resulted in an excellent 9-month outcome. This article is protected by copyright. All rights reserved.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.